Cardiac Physiology in Transgenic Mice
The DOI matches its Crossref record.
Abstract
Abstract —By use of gene targeting and/or transgenesis, it is now possible to make defined changes in genes whose functions underlie mammalian cardiovascular function. Because of technical and economic considerations, these experiments are largely confined to the mouse. Genetic modification of the loci responsible for aspects of cardiac development, differentiation, and function via gene targeting, as well as modulation of the cardiac protein complement using transgenesis, has begun to provide mouse models of cardiac hypertrophy, dilated cardiomyopathy, and hypertrophic cardiomyopathies. In order to use these animal models fully and explore their phenotypes at the whole organ and whole animal levels, the extension of cardiovascular physiological methodologies to the mouse is imperative. Techniques for exploring aspects of cardiovascular function are well developed for larger animal models, but their modification for the small size of the mouse heart and for the animal’s rapid cardiac cycle has proven to be a formidable challenge, requiring the combined efforts of the molecular biology, physiology, and cardiology communities. We review here the ability of present-day technology to obtain reproducible data on murine cardiac function at the whole organ and animal levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Cheng, Y., Samia, A. C., Meyers, J. D., Panagopoulos, I., Fei, B., & Burda, C. (2008) · Journal of the American Chemical Society · doi:10.1021/ja801631c · Cited by 733
Huynh, K., Bernardo, B. C., McMullen, J. R., & Ritchie, R. H. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.01.003 · Cited by 553
Cellular mechanisms of cardiac hypertrophy
Sugden, P. H., & Clerk, A. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050275 · Cited by 404
Dewald, O., Ren, G., Duerr, G. D., Zoerlein, M., Klemm, C., Gersch, C., Tincey, S., Michael, L. H., Entman, M. L., & Frangogiannis, N. G. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63154-9 · Cited by 382
Rodent models of diabetic cardiomyopathy
Bugger, H., & Abel, E. D. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.001941 · Cited by 285
BUTZ, G. M., & DAVISSON, R. L. (2001) · Physiological Genomics · doi:10.1152/physiolgenomics.2001.5.2.89 · Cited by 279
Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy
Huang, W.-Y., Aramburu, J., Douglas, P. S., & Izumo, S. (2000) · Nature Medicine · doi:10.1038/74914 · Cited by 271
MORLEY, G. E., VAIDYA, D., SAMIE, F. H., LO, C., DELMAR, M., & JALIFE, J. (1999) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1999.tb00192.x · Cited by 269
Sam, F., Sawyer, D. B., Chang, D. L.-F., Eberli, F. R., Ngoy, S., Jain, M., Amin, J., Apstein, C. S., & Colucci, W. S. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.1.h422 · Cited by 190
“An advantage of this method is that it allows LV size and function to be measured over a range of LV filling pressures and, thus, provides a full reflection of both chamber dilation and maximal systolic pump capacity (18).”
MethodDiabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes
Severson, D. L. (2004) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y04-065 · Cited by 111
Metadata
- Authors
- James, J. F., Hewett, T. E., & Robbins, J.
- Venue
- Circulation Research
- Published
- 1998-03-09
- Volume
- 82
- Issue
- 4
- Pages
- 407-415
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2131152789
- Cited by
- 197
- References
- 0
- FWCI
- 17.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.